AXSM: Notice to Sell 300 Shares Filed

Susan Mahony submitted a Rule 144 notice to sell 300 shares of Common Stock of Axsome Therapeutics, Inc..

Rhea-AI Filing Summary

Susan Mahony submitted a Rule 144 notice to sell 300 shares of Common Stock of Axsome Therapeutics, Inc.. The filing lists a Restricted Stock Lapse dated 06/06/2026 and a sale entry dated 06/09/2026, with Charles Schwab & Co., Inc. named as the broker.

Key Figures

Shares covered: 300 shares Restricted stock lapse date: 06/06/2026 Sale entry date: 06/09/2026 +4 more

7 metrics

Shares covered 300 shares Form 144 securities to be sold

Restricted stock lapse date 06/06/2026 Listed as "Restricted Stock Lapse" in the securities section

Sale entry date 06/09/2026 "Securities Sold During The Past 3 Months" entry

Filing/record date 06/10/2026 Date associated with the issuer/broker line

Broker Charles Schwab & Co., Inc. Broker listed in the securities section

Dollar amount shown $73,854.00 Numeric value present on the issuer/broker line

Dollar amount shown (sale) $71,163.00 Numeric value present in "Securities Sold During The Past 3 Months" row

Key Terms

Rule 144, Restricted Stock Lapse, Equity Compensation

3 terms

Rule 144 regulatory

"submitted a Rule 144 notice to sell 300 shares"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Lapse financial

"Restricted Stock Lapse | Axsome Therapeutics, Inc. | 300 | 06/06/2026"

Equity Compensation financial

"06/06/2026 | Restricted Stock Lapse | ... | Equity Compensation"

Equity compensation is pay given to employees, executives or contractors in the form of company ownership—such as stock, stock options or restricted shares—rather than just cash. It matters to investors because it can align workers' incentives with shareholders (like paying someone in slices of the same pie they help grow), but it also increases the number of shares outstanding and company expenses, affecting ownership percentages and earnings per share.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the AXSM Form 144 disclose about the transaction?

It discloses a Rule 144 notice to sell 300 shares of AXSM. The filing shows a restricted stock lapse on 06/06/2026 and a reported sale entry on 06/09/2026, with Charles Schwab & Co., Inc. listed as broker.

Who is the reporting person on the AXSM Form 144?

The reporting person is Susan Mahony. Her address appears in the filing and she is listed in connection with the 300-share transaction and the related restricted stock lapse dated 06/06/2026.

How many AXSM shares are covered by this Form 144?

The Form 144 covers 300 shares of Common Stock. That quantity appears in the securities section and in the "Securities Sold During The Past 3 Months" entry dated 06/09/2026.

Which broker is named on the AXSM Form 144?

Charles Schwab & Co., Inc. is listed with an address and appears in the securities/broker section associated with the 300-share transaction in the filing.

What event triggered the ability to sell these AXSM shares?

The filing cites a "Restricted Stock Lapse" dated 06/06/2026. That event is recorded in the securities section and precedes the reported sale entry on 06/09/2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/10/2026 - 04:17 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001463321
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Axsome Therapeutics, Inc.
SEC File Number	001-37635
Address of Issuer	ONE WORLD TRADE CENTER, 29TH FLOOR NEW YORK NEW YORK 10007
Phone	(212) 332-3241
Name of Person for Whose Account the Securities are To Be Sold	Mahony Susan
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	300	73854.00	51459766	06/10/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/06/2026	Restricted Stock Lapse	Axsome Therapeutics, Inc.			300	06/06/2026	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Susan Mahony ONE WORLD TRADE CENTER, 29TH FLOOR NEW YORK NY 10007	Axsome Therapeutics, Inc.	06/09/2026	300	71163.00

144: Remarks and Signature

Remarks
Date of Notice	06/10/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/02/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Susan Mahony
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)